Contribution of ceramides metabolism in psychiatric disorders
Journal of Neurochemistry · 2023-03 · 164 (6) · 708-724
DOI: 10.1111/jnc.15759 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, online erschienen am 17.02.2023. Verfasst von Sofía Bernal-Vega und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Biochemistry and Molecular Medicine Department, Universidad Autónoma de Nuevo León, Monterrey, Mexico. Hauptthemen laut MEDLINE: Mental Disorders, Bipolar Disorder. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: Consejo Nacional de Ciencia y Tecnología.
Abstract (Originalsprache)
Psychiatric disorders affect 970 million people worldwide, representing a significant source of disability. Although the underlying neurobiological traits for these disorders are not fully understood, a complex interplay between psychological, environmental, and biological factors contributes to their outcomes. Recent advances in lipidomic analysis and artificial intelligence algorithms have improved the identification of selective lipid species modulating the susceptibility to mental disorders. Sphingolipids (SLs) and ceramides‐related SLs are among the most abundant lipids species in the brain that support major key pathways during neurodevelopment and brain plasticity. High levels of ceramides in plasma and brain contribute to psychiatric illness susceptibility in humans and animal models. However, the neuropathological mechanism regarding the involvement of ceramides in these disorders remain inconclusive. The brain is highly susceptible to nutritional insults, which could lead to functional impairment and influence the development and progression of psychiatric disorders. While the brain relies on glucose metabolism to support its physiological needs, a selective nutrient formula appears to have greater effects on brain health than others. For instance, consumption of high‐energy diets is associated with brain anatomical, physiological, and metabolic changes, including ceramides metabolism. Herein, we will address the contribution of ceramides metabolism as a modulator of major psychiatric disorders such as depression, anxiety, bipolar disorder, schizophrenia, and attention deficit‐hyperactivity disorder. We will also describe molecular and cellular targets of ceramides metabolism assisting the maintenance and progression of psychiatric disorders and their modulation by dietary formulas as non‐pharmacologic treatments. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, Biochemistry and Molecular Medicine Department, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
- Neurometabolism Unit, Center for Research and Development in Health Sciences, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
ORCID-Profile: Sofía Bernal-Vega, Alberto Camacho-Morales
Förderung
- Consejo Nacional de Ciencia y Tecnología
Zitieren
APA
Bernal-Vega, S., García-Juárez, M., & Camacho-Morales, A. (2023). Contribution of ceramides metabolism in psychiatric disorders. Journal of Neurochemistry, 164(6), 708-724. https://doi.org/10.1111/jnc.15759
Vancouver
Bernal-Vega S, García-Juárez M, Camacho-Morales A. Contribution of ceramides metabolism in psychiatric disorders. Journal of Neurochemistry. 2023;164(6):708-724. doi:10.1111/jnc.15759
BibTeX
@article{BernalVega2023,
author = {Bernal-Vega, Sofía and García-Juárez, Martín and Camacho-Morales, Alberto},
title = {Contribution of ceramides metabolism in psychiatric disorders},
journal = {Journal of Neurochemistry},
year = {2023},
volume = {164},
number = {6},
pages = {708--724},
doi = {10.1111/jnc.15759}
}
EUVIMED